看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM P/E Multiple | -9.9x - -11.0x | -10.5x |
| Selected Fwd P/E Multiple | 190.3x - 210.4x | 200.4x |
| Fair Value | HK$ 4.62 - HK$ 5.10 | HK$ 4.86 |
| Upside | -14.6% - -5.7% | -10.1% |
| Benchmarks | - | Full Ticker |
| Beijing Succeeder Technology Inc. | 68,833,800.0% | SHSE:688338 |
| Jiangxi Sanxin Medtec Co.,Ltd. | 30,045,300.0% | SZSE:300453 |
| Shanghai ZJ Bio-Tech Co., Ltd | 68,831,700.0% | SHSE:688317 |
| Beijing Bohui Innovation Biotechnology Group Co., Ltd. | 30,031,800.0% | SZSE:300318 |
| Maider Medical Industry Equipment Co. Ltd. | 68,831,000.0% | SHSE:688310 |
| Peijia Medical Limited | 999,600.0% | SEHK:9996 |
| - | - | - |
| Select Price / LTM EPS Ratio | ||||||||
| Benchmark Companies | ||||||||
| 688338 | 300453 | 688317 | 300318 | 688310 | 9996 | |||
| SHSE:688338 | SZSE:300453 | SHSE:688317 | SZSE:300318 | SHSE:688310 | SEHK:9996 | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | 9.7% | 29.8% | NM- | 29.5% | NM- | NM- | ||
| 3Y CAGR | 5.1% | 13.4% | NM- | NM- | NM- | NM- | ||
| Latest Twelve Months | -10.0% | 10.1% | 6.9% | 137.1% | -119.8% | 42.3% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 39.3% | 15.0% | 11.7% | -16.1% | 19.1% | -1542.0% | ||
| Prior Fiscal Year | 42.4% | 15.9% | -49.9% | -2.4% | 20.8% | -89.0% | ||
| Latest Fiscal Year | 36.9% | 15.2% | -71.3% | 1.1% | -7.2% | -36.8% | ||
| Latest Twelve Months | 35.4% | 15.2% | -71.3% | 1.1% | -7.2% | -36.8% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | NA | 11.2x | -5.9x | 42.2x | 29.7x | -13.2x | ||
| Price / LTM Sales | 8.3x | 2.8x | 17.2x | 6.0x | 6.6x | 5.4x | ||
| LTM P/E Ratio | 22.8x | 18.3x | -24.1x | 548.7x | -92.6x | -14.7x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/E Ratio | -92.6x | 18.3x | 548.7x | |||||
| Historical LTM P/E Ratio | -14.7x | -12.6x | -7.1x | |||||
| Selected P/E Multiple | -9.9x | -10.5x | -11.0x | |||||
| (x) LTM Net Income | (227) | (227) | (227) | |||||
| (=) Equity Value | 2,254 | 2,373 | 2,491 | |||||
| (/) Shares Outstanding | 654.6 | 654.6 | 654.6 | |||||
| Implied Value Range | 3.44 | 3.62 | 3.81 | |||||
| FX Rate: CNY/HKD | 0.9 | 0.9 | 0.9 | Market Price | ||||
| Implied Value Range (Trading Cur) | 3.67 | 3.86 | 4.05 | 5.41 | ||||
| Upside / (Downside) | -32.3% | -28.7% | -25.1% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | 688338 | 300453 | 688317 | 300318 | 688310 | 9996 | |
| Value of Common Equity | 2,477 | 4,166 | 3,066 | 5,073 | 1,828 | 3,327 | |
| (/) Shares Outstanding | 106.1 | 514.3 | 189.8 | 816.9 | 165.8 | 654.6 | |
| Implied Stock Price | 23.34 | 8.10 | 16.15 | 6.21 | 11.03 | 5.08 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 0.94 | |
| Implied Stock Price (Trading Cur) | 23.34 | 8.10 | 16.15 | 6.21 | 11.03 | 5.41 | |
| Trading Currency | CNY | CNY | CNY | CNY | CNY | HKD | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 0.94 | |